- Home
- KALU vs ARDX Comparison
KALU vs ARDX Comparison
Compare KALU & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALU
- ARDX
- Stock Information
- Founded
- KALU 1946
- ARDX 2007
- Country
- KALU United States
- ARDX United States
- Employees
- KALU N/A
- ARDX N/A
- Industry
- KALU Metal Fabrications
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- KALU Industrials
- ARDX Health Care
- Exchange
- KALU Nasdaq
- ARDX Nasdaq
- Market Cap
- KALU 1.1B
- ARDX 1.2B
- IPO Year
- KALU 1991
- ARDX 2014
- Fundamental
- Price
- KALU $70.00
- ARDX $5.40
- Analyst Decision
- KALU Buy
- ARDX Strong Buy
- Analyst Count
- KALU 3
- ARDX 8
- Target Price
- KALU $82.33
- ARDX $11.21
- AVG Volume (30 Days)
- KALU 100.1K
- ARDX 4.4M
- Earning Date
- KALU 02-19-2025
- ARDX 02-20-2025
- Dividend Yield
- KALU 4.46%
- ARDX N/A
- EPS Growth
- KALU 252.66
- ARDX N/A
- EPS
- KALU 2.90
- ARDX N/A
- Revenue
- KALU $2,980,300,000.00
- ARDX $251,849,000.00
- Revenue This Year
- KALU N/A
- ARDX $168.07
- Revenue Next Year
- KALU $6.84
- ARDX $22.65
- P/E Ratio
- KALU $23.78
- ARDX N/A
- Revenue Growth
- KALU N/A
- ARDX 87.57
- 52 Week Low
- KALU $59.52
- ARDX $4.32
- 52 Week High
- KALU $102.42
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- KALU 31.87
- ARDX 50.60
- Support Level
- KALU $69.37
- ARDX $4.91
- Resistance Level
- KALU $72.46
- ARDX $5.18
- Average True Range (ATR)
- KALU 2.39
- ARDX 0.35
- MACD
- KALU -0.06
- ARDX 0.04
- Stochastic Oscillator
- KALU 26.12
- ARDX 70.87
About KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from United States.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.